GEMZAR Side Effects

7020948-1 | Acute Respiratory Distress Syndrome, Interstitial Lung Disease, Lymphangiosis Carcinomatosa, White Blood Cell Count Decreased
on Sep 24, 2010 Female patient from JAPAN , weighting 128.3 lb, was diagnosed with breast cancer recurrent and was treated with Gemzar (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, interstitial lung disease, lymphangiosis carcinomatosa, white blood cell count decreased. Gemzar dosage: 1250 Mg/m2, Unk. During the same period patient was treated with HERCEPTIN (2 Mg/kg, Unk) (View Herceptin Review and Herceptin Label ), VINORELBINE TARTRATE (View Vinorelbine Tartrate Review and Vinorelbine Tartrate Label ). Patient was hospitalized.

7020946-8 | Pseudomembranous Colitis
Patient was taking Gemzar (View Usage). Patient had the following side effects: pseudomembranous colitis on Sep 20, 2010 from FRANCE Additional patient health information: Female patient , 63 years of age, was diagnosed with pancreatic carcinoma, urinary tract infection (What is urinary tract infection?) and. Gemzar dosage: . During the same period patient was treated with CEFPODOXIME PROXETIL (View Cefpodoxime Proxetil Review and Cefpodoxime Proxetil Label ), KARDEGIC (160 Mg, Daily (1/d)) (View Kardegic Review and Kardegic Label ), KEPPRA (160 Mg, Daily (1/d)) (View Keppra Review and Keppra Label ), NEXIUM (20 Mg, Daily (1/d)) (View Nexium Review and Nexium Label ), LASIX (40 Mg, Daily (1/d)) (View Lasix Review and Lasix Label ). Patient was hospitalized.

7019141-8 | Hospitalisation, Renal Failure
Adverse event was reported on Sep 16, 2010 by a Male patient taking Gemzar (View Usage) (Dosage: ) was diagnosed with pancreatic carcinoma metastatic and. Location: AUSTRALIA , 51 years of age, After Gemzar was administered, patient had the following side effects: hospitalisation, renal failure. During the same period patient was treated with CREON (View Creon Review and Creon Label ), COLOXYL WITH SENNA (View Coloxyl With Senna Review and Coloxyl With Senna Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), MEXITIL (View Mexitil Review and Mexitil Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), DILAUDID (View Dilaudid Review and Dilaudid Label ), CLONIDINE (View Clonidine Review and Clonidine Label ). Patient was hospitalized.

7019138-8 | Granuloma, Haematoma, Pancreatic Enlargement, Vascular Pseudoaneurysm, Vascular Pseudoaneurysm Ruptured
on Sep 22, 2010 Male patient from JAPAN , weighting 147.7 lb, was diagnosed with pancreatic carcinoma stage iv, prophylaxis and was treated with Gemzar (View Usage). Patient experienced the following unwanted or unexpected effects: granuloma, haematoma, pancreatic enlargement, vascular pseudoaneurysm, vascular pseudoaneurysm ruptured. Gemzar dosage: 1700 Mg, Other. During the same period patient was treated with DECADRON /00016002/ (3.3 Mg, Other) (View Decadron /00016002/ Review and Decadron /00016002/ Label ), RAMELTEON (0.3 Mg, Other) (View Ramelteon Review and Ramelteon Label ).


7015312-5 | Myalgia, Pancytopenia, Rash Maculo-papular, Visual Impairment
on Sep 15, 2010 Female patient from FRANCE , 68 years of age, was diagnosed with lymphoma (What is lymphoma?) and was treated with Gemzar (View Usage). Patient had the following side effects: myalgia, pancytopenia, rash maculo-papular, visual impairment. Gemzar dosage: . During the same period patient was treated with NAVELBINE (View Navelbine Review and Navelbine Label ), CAELYX (View Caelyx Review and Caelyx Label ).

7015310-1 | Small Intestinal Perforation
Patient was taking Gemzar (View Usage). After Gemzar was administered, patient had the following side effects: small intestinal perforation on Sep 22, 2010 from JAPAN Additional patient health information: Female patient , 71 years of age, was diagnosed with pancreatic carcinoma and. Gemzar dosage: Unk, Other.

7013668-0 | Blood Pressure Decreased, Chest Pain, Dizziness, Dyspnoea, Erythema, Hyperhidrosis, Neuralgia
Adverse event was reported on Sep 17, 2010 by a Male patient taking Gemzar (View Usage) (Dosage: ) . Location: FINLAND , weighting 189.6 lb, Patient experienced the following unwanted or unexpected effects: blood pressure decreased, chest pain (What is chest pain?), dizziness (What is dizziness?), dyspnoea, erythema, hyperhidrosis, neuralgia. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

7013667-9 | Chest X-ray Abnormal, Cough, Pyrexia
on Sep 14, 2010 Female patient from CHINA , 67 years of age, was diagnosed with ureteric cancer and was treated with Gemzar (View Usage). Patient had the following side effects: chest x-ray abnormal, cough, pyrexia. Gemzar dosage: 1.6 G, 1st Day Of 21day Cycle. During the same period patient was treated with NORMAL SALINE (500 Ml, As Needed) (View Normal Saline Review and Normal Saline Label ).

7008232-3 | Hepatic Atrophy
on Sep 13, 2010 Female patient from JAPAN , 66 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar (View Usage). After Gemzar was administered, patient had the following side effects: hepatic atrophy. Gemzar dosage: . During the same period patient was treated with TS 1 (View Ts 1 Review and Ts 1 Label ).

7008227-X | Anaemia Macrocytic
Patient was taking Gemzar (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia macrocytic on Sep 14, 2010 from JAPAN Additional patient health information: Male patient , 75 years of age, was diagnosed with pancreatic carcinoma and. Gemzar dosage: 1500 Mg, Unk. During the same period patient was treated with TS 1 (80 Mg, Unk) (View Ts 1 Review and Ts 1 Label ).

7003292-8 | Ileus, Malignant Ascites, Off Label Use
Adverse event was reported on Sep 14, 2010 by a Female patient taking Gemzar (View Usage) (Dosage: 1390 Mg, Other) was diagnosed with ovarian cancer and. Location: JAPAN , 64 years of age, Patient had the following side effects: ileus, malignant ascites, off label use. During the same period patient was treated with TAXOTERE (150 Mg, Other) (View Taxotere Review and Taxotere Label ). Patient was hospitalized.

6998086-3 | Neuroleptic Malignant Syndrome
on Sep 07, 2010 Female patient from UNITED STATES , 72 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Gemzar (View Usage). After Gemzar was administered, patient had the following side effects: neuroleptic malignant syndrome. Gemzar dosage: 1900 Mg, Unk.

6998085-1 | Atrial Fibrillation, Cardiac Arrest, Hot Flush, Leukocytosis, Malignant Neoplasm Progression, Off Label Use, Pleural Effusion, Pneumonia, Staphylococcal Sepsis
on Sep 14, 2010 Female patient from UNITED STATES , weighting 118.0 lb, was diagnosed with diffuse large b-cell lymphoma, intracardiac thrombus and was treated with Gemzar (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), cardiac arrest (What is cardiac arrest?), hot flush, leukocytosis, malignant neoplasm progression, off label use, pleural effusion, pneumonia (What is pneumonia?), staphylococcal sepsis. Gemzar dosage: 800 Mg, Days 2 And 15. During the same period patient was treated with OXALIPLATIN (80 Mg, Days 2 And 15) (View Oxaliplatin Review and Oxaliplatin Label ), RITUXIMAB (600 Mg, Day 1) (View Rituximab Review and Rituximab Label ), NEULASTA (6 Mg, Day 3) (View Neulasta Review and Neulasta Label ), DECADRON (20 Mg, Days 1, 2, And 15) (View Decadron Review and Decadron Label ), BENADRYL (25 Mg, Days 1,2 And 15) (View Benadryl Review and Benadryl Label ), ZANTAC (50 Mg, Days 1,2, And 15) (View Zantac Review and Zantac Label ), KYTRIL (1 Mg, Days 1, 2, And 15) (View Kytril Review and Kytril Label ), COUMADIN (4 Mg, Mon, Wed, Fri) (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

6998082-6 | Dehydration, Neutropenia, Off Label Use
Patient was taking Gemzar (View Usage). Patient had the following side effects: dehydration, neutropenia, off label use on Sep 07, 2010 from UNITED STATES Additional patient health information: Female patient , 48 years of age, weighting 161.9 lb, was diagnosed with renal cell carcinoma, metastatic renal cell carcinoma and. Gemzar dosage: 90 Mg, Other. During the same period patient was treated with AXITINIB (10 Mg, 2/d) (View Axitinib Review and Axitinib Label ), DOXORUBICIN HCL (2680 Mg, Unk) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), NEULASTA (6 Mg, Unk) (View Neulasta Review and Neulasta Label ). Patient was hospitalized.

6988289-6 | Myositis, Rhabdomyolysis
Adverse event was reported on Sep 16, 2010 by a Female patient taking Gemzar (View Usage) (Dosage: 180 Mg, Weekly (1/w)) was diagnosed with ovarian neoplasm and. Location: SPAIN , 64 years of age, After Gemzar was administered, patient had the following side effects: myositis (What is myositis?), rhabdomyolysis. During the same period patient was treated with TAXOL (140 Mg (6mg/ml) Every 2 Weeks) (View Taxol Review and Taxol Label ). Patient was hospitalized.

6984690-5 | Dyspnoea, Fatigue, Malignant Neoplasm Progression, Pleural Effusion, Radiation Myelopathy
on Sep 08, 2010 Male patient from NEW ZEALAND , 55 years of age, was treated with Gemzar (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, fatigue, malignant neoplasm progression, pleural effusion, radiation myelopathy. Gemzar dosage: . During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

6983386-3 | Dyspnoea, Myocardial Infarction
on Sep 14, 2010 Female patient from UNITED STATES , 61 years of age, weighting 147.7 lb, was diagnosed with lung neoplasm malignant and was treated with Gemzar (View Usage). Patient had the following side effects: dyspnoea, myocardial infarction. Gemzar dosage: . Patient was hospitalized.

6980844-2 | Altered State Of Consciousness, Disseminated Intravascular Coagulation, Liver Abscess, Liver Disorder, Sepsis, Subdiaphragmatic Abscess
Patient was taking Gemzar (View Usage). After Gemzar was administered, patient had the following side effects: altered state of consciousness, disseminated intravascular coagulation, liver abscess, liver disorder, sepsis (What is sepsis?), subdiaphragmatic abscess on Sep 08, 2010 from JAPAN Additional patient health information: Male patient , 72 years of age, was diagnosed with bile duct cancer and. Gemzar dosage: Unk, Unk. During the same period patient was treated with FLUOROURACIL (Unk, Unk) (View Fluorouracil Review and Fluorouracil Label ).

6980839-9 | Toxic Epidermal Necrolysis
Adverse event was reported on Sep 10, 2010 by a Male patient taking Gemzar (View Usage) (Dosage: ) . Location: JAPAN , 53 years of age, Patient experienced the following unwanted or unexpected effects: toxic epidermal necrolysis. Patient was hospitalized.

6979435-9 | Ileus, Malignant Ascites, Off Label Use
on Sep 03, 2010 Female patient from JAPAN , 64 years of age, was diagnosed with ovarian cancer and was treated with Gemzar (View Usage). Patient had the following side effects: ileus, malignant ascites, off label use. Gemzar dosage: Unk, Other. During the same period patient was treated with TAXOTERE (Unk, Other) (View Taxotere Review and Taxotere Label ).

6979424-4 | Pernicious Anaemia
on Sep 03, 2010 Male patient from JAPAN , 75 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar (View Usage). After Gemzar was administered, patient had the following side effects: pernicious anaemia. Gemzar dosage: 1500 Mg, Unk. During the same period patient was treated with TS 1 (80 Mg, Unk) (View Ts 1 Review and Ts 1 Label ).

6977427-7 | Atelectasis, Malignant Neoplasm Progression, Pneumonitis
Patient was taking Gemzar (View Usage). Patient experienced the following unwanted or unexpected effects: atelectasis, malignant neoplasm progression, pneumonitis on Aug 30, 2010 from DENMARK Additional patient health information: Male patient , weighting 134.5 lb, was diagnosed with bladder cancer (What is bladder cancer?), pain (What is pain?) and. Gemzar dosage: 2000 Mg, Every 1st And 8th Day. During the same period patient was treated with PREDNISOLONE (25 Mg, Daily (1/d)) (View Prednisolone Review and Prednisolone Label ), PAMOL (2 D/f, 2/d) (View Pamol Review and Pamol Label ), CONTALGIN (10 Mg, Daily (1/d)) (View Contalgin Review and Contalgin Label ). Patient was hospitalized.

6969324-8 | Anaemia, Gastrointestinal Haemorrhage, Ischaemia
Adverse event was reported on Aug 26, 2010 by a Female patient taking Gemzar (View Usage) (Dosage: 1000 Mg/m2, Other) was diagnosed with ovarian cancer and. Location: UNITED STATES , weighting 125.0 lb, Patient had the following side effects: anaemia, gastrointestinal haemorrhage, ischaemia. During the same period patient was treated with VESICARE (View Vesicare Review and Vesicare Label ). Patient was hospitalized.

6969303-0 | Chest X-ray Abnormal, Cough, Pyrexia
on Aug 27, 2010 Female patient from CHINA , 67 years of age, was diagnosed with ureteric cancer and was treated with Gemzar (View Usage). After Gemzar was administered, patient had the following side effects: chest x-ray abnormal, cough, pyrexia. Gemzar dosage: 1.6 G, 1st Day Of 21day Cycle. During the same period patient was treated with NORMAL SALINE (500 Ml, As Needed) (View Normal Saline Review and Normal Saline Label ).

6965560-5 | Arthralgia, Depression, Inflammation, Insomnia, Oedema Peripheral
on Aug 23, 2010 Male patient from FRANCE , weighting 154.3 lb, was treated with Gemzar (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, depression (What is depression?), inflammation, insomnia, oedema peripheral. Gemzar dosage: . Patient was hospitalized and became disabled.

6963026-X | Convulsion, Electrolyte Imbalance, Menorrhagia, Myocardial Infarction, Respiratory Failure
Patient was taking Gemzar (View Usage). Patient had the following side effects: convulsion, electrolyte imbalance, menorrhagia, myocardial infarction, respiratory failure on Aug 26, 2010 from CHINA Additional patient health information: Female patient , 48 years of age, was diagnosed with adenocarcinoma and. Gemzar dosage: 1.6 G, On Day 1 And 8. During the same period patient was treated with CISPLATIN (30 Mg, On Day 1 And 4) (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

6955365-3 | Asthenia, Muscle Spasms, Pain In Extremity, Pyrexia
Adverse event was reported on Aug 17, 2010 by a Female patient taking Gemzar (View Usage) (Dosage: ) was diagnosed with pancreatic carcinoma and. Location: UNITED KINGDOM , 67 years of age, weighting 130.1 lb, After Gemzar was administered, patient had the following side effects: asthenia, muscle spasms, pain in extremity, pyrexia. During the same period patient was treated with ACETAMINOPHEN AND CODEINE PHOSPHATE (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6955364-1 | Arrhythmia, Arthralgia, Gait Disturbance, Myalgia
on Aug 17, 2010 Male patient from UNITED KINGDOM , 76 years of age, weighting 158.7 lb, was diagnosed with pancreatic carcinoma, pancreatectomy and was treated with Gemzar (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), arthralgia, gait disturbance, myalgia. Gemzar dosage: . During the same period patient was treated with CREON (View Creon Review and Creon Label ), ISTIN (View Istin Review and Istin Label ).

6946145-3 | Blood Alkaline Phosphatase Increased, Cerebrovascular Accident, Gamma-glutamyltransferase Increased, Hemiparesis
on Aug 17, 2010 Male patient from FRANCE , weighting 145.5 lb, was diagnosed with pancreatic carcinoma metastatic, pain (What is pain?), abdominal pain upper, thrombosis and was treated with Gemzar (View Usage). Patient had the following side effects: blood alkaline phosphatase increased, cerebrovascular accident, gamma-glutamyltransferase increased, hemiparesis. Gemzar dosage: 1000 Mg, Cycle 1 Of 8 Weeks Duration And Then Cycles Of 4 Weeks.. During the same period patient was treated with EFFERALGAN CODEINE (6 D/f, Daily (1/d)) (View Efferalgan Codeine Review and Efferalgan Codeine Label ), OMEPRAZOLE (1 D/f, Daily (1/d)) (View Omeprazole Review and Omeprazole Label ), INNOHEP (1 D/f, Daily (1/d)) (View Innohep Review and Innohep Label ).

6938092-8 | Atypical Mycobacterial Infection, Decreased Appetite, Duodenal Stenosis, Malignant Neoplasm Progression
Patient was taking Gemzar (View Usage). After Gemzar was administered, patient had the following side effects: atypical mycobacterial infection, decreased appetite, duodenal stenosis, malignant neoplasm progression on Aug 20, 2010 from JAPAN Additional patient health information: Male patient , 71 years of age, was diagnosed with pancreatic carcinoma stage iv and. Gemzar dosage: . Patient was hospitalized.

6938090-4 | Fatigue, Multi-organ Failure
Adverse event was reported on Aug 18, 2010 by a Male patient taking Gemzar (View Usage) (Dosage: 1000 Mg/m2, Other) was diagnosed with pancreatic carcinoma stage iv and. Location: JAPAN , 62 years of age, Patient experienced the following unwanted or unexpected effects: fatigue, multi-organ failure.

6936916-1 | Arthralgia
on Aug 16, 2010 Male patient from JAPAN , 78 years of age, was diagnosed with transitional cell carcinoma and was treated with Gemzar (View Usage). Patient had the following side effects: arthralgia. Gemzar dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), PALONOSETRON HYDROCHLORIDE (View Palonosetron Hydrochloride Review and Palonosetron Hydrochloride Label ).

6936915-X | Cholangitis Acute, Interstitial Lung Disease
on Aug 18, 2010 Female patient from JAPAN , weighting 97.00 lb, was diagnosed with pancreatic carcinoma stage iv, gastric ulcer, cancer pain and was treated with Gemzar (View Usage). After Gemzar was administered, patient had the following side effects: cholangitis acute, interstitial lung disease. Gemzar dosage: 1200 Mg, Other. During the same period patient was treated with RABEPRAZOLE SODIUM (10 Mg, Daily (1/d)) (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), LOXONIN (60 Mg, 3/d) (View Loxonin Review and Loxonin Label ), DUROTEP (125 Mg, Daily (1/d)) (View Durotep Review and Durotep Label ). Patient was hospitalized.

6936912-4 | Abdominal Pain Upper, Nausea
Patient was taking Gemzar (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, nausea (What is nausea?) on Aug 11, 2010 from AUSTRIA Additional patient health information: Female patient , 69 years of age, was diagnosed with pancreatic carcinoma and. Gemzar dosage: . During the same period patient was treated with NOVALGIN (40 D/f, 3/d) (View Novalgin Review and Novalgin Label ), TARCEVA (100 Mg Pills, Daily (1/d)) (View Tarceva Review and Tarceva Label ), LORAZEPAM (1 Mg Pills, Daily (1/d)) (View Lorazepam Review and Lorazepam Label ), ZURCAL (20 Mg Pills, Daily (1/d)) (View Zurcal Review and Zurcal Label ). Patient was hospitalized.

6932839-2 | Disseminated Intravascular Coagulation, Interstitial Lung Disease
Adverse event was reported on Aug 11, 2010 by a Male patient taking Gemzar (View Usage) (Dosage: 1510 Mg, Unk) was diagnosed with pancreatic carcinoma stage iv and. Location: JAPAN , 61 years of age, weighting 152.1 lb, Patient had the following side effects: disseminated intravascular coagulation, interstitial lung disease. During the same period patient was treated with TS 1 (40 Mg, 2/d) (View Ts 1 Review and Ts 1 Label ), LOXONIN (60 Mg, 3/d) (View Loxonin Review and Loxonin Label ), ALTAT (37.5 Mg, 3/d) (View Altat Review and Altat Label ), KADIAN (20 Mg, Daily (1/d)) (View Kadian Review and Kadian Label ). Patient was hospitalized.

6931120-5 | Blood Albumin Decreased, Blood Creatinine Decreased, Blood Glucose Increased, Peripheral Ischaemia
on Aug 06, 2010 Female patient from UNITED STATES , weighting 115.0 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar (View Usage). After Gemzar was administered, patient had the following side effects: blood albumin decreased, blood creatinine decreased, blood glucose increased, peripheral ischaemia. Gemzar dosage: 1550 Mg, Unk.

6931117-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Creatine Phosphokinase Increased, Gamma-glutamyltransferase Increased, Platelet Count Increased, Rhabdomyolysis
on Aug 06, 2010 Male patient from GERMANY , weighting 154.3 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatine phosphokinase increased, gamma-glutamyltransferase increased, platelet count increased, rhabdomyolysis. Gemzar dosage: 1640 Mg, Weekly (1/w). During the same period patient was treated with ERLOTINIB HYDROCHLORIDE (100 Mg, Daily (1/d)) (View Erlotinib Hydrochloride Review and Erlotinib Hydrochloride Label ).

6929160-5 | Febrile Neutropenia, Septic Shock
Patient was taking Gemzar (View Usage). Patient had the following side effects: febrile neutropenia, septic shock on Aug 17, 2010 from JAPAN Additional patient health information: Female patient , 45 years of age, was diagnosed with gallbladder cancer non-resectable and. Gemzar dosage: . During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

6928884-3 | Nephritis Allergic
Adverse event was reported on Aug 05, 2010 by a Female patient taking Gemzar (View Usage) (Dosage: ) . Location: UNITED STATES , 64 years of age, After Gemzar was administered, patient had the following side effects: nephritis allergic. During the same period patient was treated with ALIMTA (500 Mg/m2, Unk) (View Alimta Review and Alimta Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6927203-6 | Activated Partial Thromboplastin Time Abnormal, Activated Partial Thromboplastin Time Prolonged, Blood Albumin Decreased, Blood Fibrinogen Abnormal, Blood Fibrinogen Increased, Disseminated Intravascular Coagulation, Erythema, Feeling Cold
on Aug 03, 2010 Male patient from UNITED STATES , weighting 123.7 lb, was diagnosed with bone sarcoma and was treated with Gemzar (View Usage). Patient experienced the following unwanted or unexpected effects: activated partial thromboplastin time abnormal, activated partial thromboplastin time prolonged, blood albumin decreased, blood fibrinogen abnormal, blood fibrinogen increased, disseminated intravascular coagulation, erythema, feeling cold. Gemzar dosage: . During the same period patient was treated with MEPACT (3 Mg, 2/d) (View Mepact Review and Mepact Label ), BACTRIM (View Bactrim Review and Bactrim Label ), CHOLECALCIFEROL (View Cholecalciferol Review and Cholecalciferol Label ), HYDROXYZINE PAMOATE (View Hydroxyzine Pamoate Review and Hydroxyzine Pamoate Label ), ZOFRAN (View Zofran Review and Zofran Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ), DOCETAXEL (View Docetaxel Review and Docetaxel Label ). Patient was hospitalized.

6927201-2 | Acute Interstitial Pneumonitis, Bacterial Infection, Dehydration, Face Oedema, Oedema Peripheral, Pyrexia, Respiratory Tract Infection Fungal
on Aug 10, 2010 Female patient from JAPAN , weighting 114.6 lb, was diagnosed with breast cancer stage iv and was treated with Gemzar (View Usage). Patient had the following side effects: acute interstitial pneumonitis, bacterial infection (What is bacterial infection?), dehydration, face oedema, oedema peripheral, pyrexia, respiratory tract infection fungal. Gemzar dosage: 800 Mg, Weekly (1/w). During the same period patient was treated with ZOMETA (View Zometa Review and Zometa Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ). Patient was hospitalized.

6927199-7 | Blood Sodium Decreased, Haematocrit Decreased, Haemoglobin Decreased, Malignant Neoplasm Progression, Platelet Count Decreased
Patient was taking Gemzar (View Usage). After Gemzar was administered, patient had the following side effects: blood sodium decreased, haematocrit decreased, haemoglobin decreased, malignant neoplasm progression, platelet count decreased on Aug 10, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 129.0 lb, was diagnosed with pancreatic carcinoma metastatic, rash (What is rash?), insomnia, pain (What is pain?), oedema peripheral and. Gemzar dosage: Unk, Unk. During the same period patient was treated with ERBITUX (View Erbitux Review and Erbitux Label ), ATENOLOL (50 Mg, Unk) (View Atenolol Review and Atenolol Label ), CLINDAMYCIN (30 G, As Needed) (View Clindamycin Review and Clindamycin Label ), CREON (Unk, Other) (View Creon Review and Creon Label ), DARVON N (Unk, Each Evening) (View Darvon-n Review and Darvon-n Label ), HYDROCODONE BITARTRATE AND ACETAMINOPHEN (7.5 Mg, Other) (View Hydrocodone Bitartrate And Acetaminophen Review and Hydrocodone Bitartrate And Acetaminophen Label ), LANTUS (48 U, Each Evening) (View Lantus Review and Lantus Label ), LASIX (60 Mg, As Needed) (View Lasix Review and Lasix Label ). Patient was hospitalized.

6921933-8 | Cholangitis Acute, Interstitial Lung Disease
Adverse event was reported on Aug 09, 2010 by a Female patient taking Gemzar (View Usage) (Dosage: 1200 Mg, Other) was diagnosed with pancreatic carcinoma stage iv, gastric ulcer, cancer pain and. Location: JAPAN , weighting 97.00 lb, Patient experienced the following unwanted or unexpected effects: cholangitis acute, interstitial lung disease. During the same period patient was treated with RABEPRAZOLE SODIUM (10 Mg, Daily (1/d)) (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), LOXONIN (60 Mg, 3/d) (View Loxonin Review and Loxonin Label ), DUROTEP (125 Mg, Daily (1/d)) (View Durotep Review and Durotep Label ). Patient was hospitalized.

6921931-4 | Deafness Neurosensory
on Aug 04, 2010 Male patient from JAPAN , 72 years of age, was diagnosed with bile duct cancer and was treated with Gemzar (View Usage). Patient had the following side effects: deafness neurosensory. Gemzar dosage: 1200 Mg, Unk. During the same period patient was treated with KYTRIL (View Kytril Review and Kytril Label ), DECADRON (View Decadron Review and Decadron Label ).

6917727-X | Alanine Aminotransferase Increased, Altered State Of Consciousness, Anaemia, Aspartate Aminotransferase Increased, Asthenia, Blood Creatinine Increased, Blood Urea Increased, Brain Oedema, Bronchial Wall Thickening
on Jul 27, 2010 Female patient from UNITED STATES , weighting 171.3 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar (View Usage). After Gemzar was administered, patient had the following side effects: alanine aminotransferase increased, altered state of consciousness, anaemia, aspartate aminotransferase increased, asthenia, blood creatinine increased, blood urea increased, brain oedema, bronchial wall thickening. Gemzar dosage: 1840 Mg, Unk. During the same period patient was treated with CETUXIMAB (736 Mg, Unk) (View Cetuximab Review and Cetuximab Label ), CISPLATIN (135 Mg, Unk) (View Cisplatin Review and Cisplatin Label ), DIPHENHYDRAMINE HYDROCHLORIDE (50 Mg, Unk) (View Diphenhydramine Hydrochloride Review and Diphenhydramine Hydrochloride Label ), ACETAMINOPHEN (650 Mg, Unk) (View Acetaminophen Review and Acetaminophen Label ), PALONOSETRON HYDROCHLORIDE (0.25 Mg, Unk) (View Palonosetron Hydrochloride Review and Palonosetron Hydrochloride Label ), DEXAMETHASONE SODIUM PHOSPHATE (20 Mg, Unk) (View Dexamethasone Sodium Phosphate Review and Dexamethasone Sodium Phosphate Label ), EMEND TRIFOLD (View Emend Trifold Review and Emend Trifold Label ). Patient was hospitalized.

6915560-6 | Mitral Valve Incompetence, Pulmonary Hypertension
Patient was taking Gemzar (View Usage). Patient experienced the following unwanted or unexpected effects: mitral valve incompetence, pulmonary hypertension (What is pulmonary hypertension?) on Jul 28, 2010 from ITALY Additional patient health information: Male patient , 71 years of age, was diagnosed with metastatic renal cell carcinoma and. Gemzar dosage: 600 Mg/m2, On Days 1 And 8 Every 28 Days. During the same period patient was treated with FLUOROURACIL (400 Mg/m2, On Days 1 And 8 Every 28 Days) (View Fluorouracil Review and Fluorouracil Label ), BEVACIZUMAB (10 Mg/kg, Every 2 Weeks) (View Bevacizumab Review and Bevacizumab Label ), PROLEUKIN (1000000 D/f, Twice A Day On Every 8,9,15,16 Day In Cycle) (View Proleukin Review and Proleukin Label ).

6909602-1 | Neutrophil Count Decreased
Adverse event was reported on Jul 28, 2010 by a Female patient taking Gemzar (View Usage) (Dosage: 1000 Mg/m2, Other) was diagnosed with transitional cell carcinoma and. Location: JAPAN , 40 years of age, Patient had the following side effects: neutrophil count decreased. During the same period patient was treated with CISPLATIN (70 Mg/m2, Other) (View Cisplatin Review and Cisplatin Label ).

6909601-X | Gastric Ulcer Haemorrhage, Neutrophil Count Decreased
on Jul 28, 2010 Male patient from JAPAN , 67 years of age, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar (View Usage). After Gemzar was administered, patient had the following side effects: gastric ulcer haemorrhage, neutrophil count decreased. Gemzar dosage: 1000 Mg, Other. During the same period patient was treated with TS 1 /JPN/ (100 Mg, Other) (View Ts 1 /jpn/ Review and Ts 1 /jpn/ Label ).

6909596-9 | Back Pain, Influenza, Lung Infiltration, Musculoskeletal Stiffness, Neutrophil Count Abnormal, Pulmonary Toxicity, Respiratory Failure, Skin Discolouration
on Jul 27, 2010 Male patient from UNITED STATES , 66 years of age, weighting 217.0 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), influenza, lung infiltration, musculoskeletal stiffness, neutrophil count abnormal, pulmonary toxicity, respiratory failure, skin discolouration. Gemzar dosage: 2240 Mg, Weekly For 3 Wks Then Off 1 Wk. During the same period patient was treated with MUSCLE RELAXANTS (View Muscle Relaxants Review and Muscle Relaxants Label ). Patient was hospitalized.

6909594-5 | Atypical Mycobacterial Infection, Decreased Appetite, Duodenal Stenosis, Malignant Neoplasm Progression
Patient was taking Gemzar (View Usage). Patient had the following side effects: atypical mycobacterial infection, decreased appetite, duodenal stenosis, malignant neoplasm progression on Jul 28, 2010 from JAPAN Additional patient health information: Male patient , 71 years of age, was diagnosed with pancreatic carcinoma stage iv and. Gemzar dosage: . Patient was hospitalized.